Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek C Goodoory

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Drugs|May 15, 2023
Antibiotics and Probiotics for Irritable Bowel SyndromeVivek C Goodoory, Alexander C Ford
The American Journal of Gastroenterology|November 2, 2020
Efficacy of Senna and Magnesium Oxide for the Treatment of Chronic Idiopathic ConstipationVivek C Goodoory, Christopher J Black, Alexander C Ford
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 29, 2024
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel SyndromeVivek C Goodoory, Mais Khasawneh, Christopher J Black, et al.
Neurogastroenterology and Motility|March 30, 2026
Natural History of Psychological Symptoms in Individuals With Rome IV Irritable Bowel Syndrome and Association With Gastrointestinal Symptom SeverityMais Khasawneh, Vivek C Goodoory, Alexander C Ford, et al.
Neurogastroenterology and Motility|September 17, 2021
Characteristics of, and natural history among, individuals with Rome IV functional bowel disordersVivek C Goodoory, Lesley A Houghton, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Impact of Rome IV irritable bowel syndrome on work and activities of daily livingVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Neurogastroenterology and Motility|September 30, 2022
Willingness to pay for medications among patients with Rome IV Irritable Bowel SyndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2023
ReplyVivek C Goodoory, Ashok K Tuteja, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and BurdenChristopher J Black, Cho-Ee Ng, Vivek C Goodoory, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Drugs|May 15, 2023
Antibiotics and Probiotics for Irritable Bowel SyndromeVivek C Goodoory, Alexander C Ford
The American Journal of Gastroenterology|November 2, 2020
Efficacy of Senna and Magnesium Oxide for the Treatment of Chronic Idiopathic ConstipationVivek C Goodoory, Christopher J Black, Alexander C Ford
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 29, 2024
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel SyndromeVivek C Goodoory, Mais Khasawneh, Christopher J Black, et al.
Neurogastroenterology and Motility|March 30, 2026
Natural History of Psychological Symptoms in Individuals With Rome IV Irritable Bowel Syndrome and Association With Gastrointestinal Symptom SeverityMais Khasawneh, Vivek C Goodoory, Alexander C Ford, et al.
Neurogastroenterology and Motility|September 17, 2021
Characteristics of, and natural history among, individuals with Rome IV functional bowel disordersVivek C Goodoory, Lesley A Houghton, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|July 7, 2022
Impact of Rome IV irritable bowel syndrome on work and activities of daily livingVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Neurogastroenterology and Motility|September 30, 2022
Willingness to pay for medications among patients with Rome IV Irritable Bowel SyndromeVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: risky business. What do sufferers' perceptions of risk from interventions for IBS really mean? Authors' replyVivek C Goodoory, Cho Ee Ng, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 22, 2023
ReplyVivek C Goodoory, Ashok K Tuteja, Christopher J Black, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2023
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and BurdenChristopher J Black, Cho-Ee Ng, Vivek C Goodoory, et al.
Pageof 4